Investor/Media Information

2019 Press Releases

Keyword Search
 
2019 | 2018 | 2017

June 26, 2019: Abeona Therapeutics Appoints Dr. Victor Paulus Senior Vice President of Regulatory Affairs

June 18, 2019: Abeona Therapeutics Receives FDA Fast Track Designation for ABO-202 AAV9 Gene Therapy in CLN1 Disease

May 21, 2019: Abeona Therapeutics Announces FDA Clearance of Investigational New Drug Application for ABO-202 Gene Therapy in CLN1 Disease

May 14, 2019: Abeona Therapeutics Treats First Patient in Second Cohort of Phase 1/2 Clinical Trial for ABO-101 in Sanfilippo Syndrome Type B (MPS IIIB)

May 10, 2019: Abeona Therapeutics Reports First Quarter 2019 Financial Results and Business Highlights

May 8, 2019: Abeona Therapeutics Announces Presentation of EB-101 Data at Society for Investigative Dermatology Annual Meeting

May 7, 2019: Abeona Therapeutics Announces Participation in Upcoming Investor Conferences

May 1, 2019: Abeona Therapeutics Reports Preclinical Data Demonstrating Broad Therapeutic Potential of AIM™ Gene Therapy in Retinal Diseases at Association for Research in Vision and Ophthalmology Annual Meeting

April 30, 2019: Abeona Therapeutics to Report New Preclinical Data Demonstrating Therapeutic Potential of ABO-401 for Treatment of Cystic Fibrosis at American Society of Gene and Cell Therapy Annual Meeting

April 15, 2019: Abeona Therapeutics to Present Data for ABO-401 in Cystic Fibrosis and Retinal Disorders at the American Society of Gene and Cell Therapy Annual Meeting

April 4, 2019: Abeona Therapeutics Receives FDA Fast Track Designation for ABO-101 for Treatment of Sanfilippo Syndrome Type B (MPS IIIB)

March 18, 2019: Abeona Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results

February 22, 2019: Abeona Therapeutics Announces Participation in 8th Annual SVB Leerink Global Healthcare Conference

February 11, 2019: Abeona Therapeutics Appoints João Siffert, M.D. Chief Executive Officer

January 31, 2019: Abeona Therapeutics to Present New Supportive Data for Novel Gene Therapies at WORLDSymposium™

January 8, 2019: Abeona Therapeutics Strengthens Financial Leadership with New Executive Appointments